News
Vaccines using mRNA are currently being studied for a wide range of diseases, including cancer, cardiovascular disease, ...
Hosted on MSN2mon
Alltrna plans to tackle rare diseases using tRNA-based therapiesEven with novel technologies like gene therapy, gene editing, or mRNA, each must address a specific ... and phenylketonuria (PKU). One of the interesting parts of Alltrna’s approach is the ...
BioMarin Pharma has had another setback in its gene therapy development programme, announcing this morning that the FDA has placed a phase 1/2 trial of its candidate for phenylketonuria (PKU ...
in Chicago April 25-30 and the American Society of Gene and Cell Therapy (ASGCT) in New Orleans May 13-17. The proof-of-concept studies demonstrate that Strand’s programmable mRNA genetic ...
"We are pushing the frontier of mRNA therapy for cancer with our novel mRNA-LNP formulation," said Dr. Steve Slilaty, CEO of the Company. "Delivering mRNA via Lipid Nanoparticles (mRNA-LNP ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results